Objections are made to the conclusions of Tolis and Naftolin that bromocriptine should be considered for induction of menstruation in women with normal serum prolactin. Amenorrhea with normal follicle stimulating hormone (FSH) and luteinizing hormone (LH) levels is often resolved spontaneously. Treatment with bromocriptine and return of menstruation cannot be considered a cause-and-effect relationship. It cannot be correct to show the magnitude of short-time oscillations in terms of percentages. Using normal statistics for standard deviations on values from Figure 1, the values for FSH and LH do not agree with the authors' conclusions. The use of bromocriptine in menstrual disorders should be restricted to women with hyperprolactinemic amenorrhea, oligomenorrhea, or luteal phase defects.